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Abstract
Aims Acute heart failure (AHF) is one of the leading causes of unscheduled hospitalization and is associated with frequent
readmissions and substantial mortality. Precipitating factors of AHF inﬂuence short-term mortality, but their effect on outcome
after hospital discharge is unknown. The present study assessed the effect of precipitating factors on readmission and
long-term survival in the overall population and in patients aged 75 years or younger.
Methods and results Patients admitted with AHF (n = 755) included in the multicentre cohort ‘Biomarcoeurs’ were included
in the study. Precipitating factors of AHF were classiﬁed in four main groups: acute coronary syndrome, atrial ﬁbrillation, acute
pulmonary disease and other causes. Hospital readmission during 90 days after discharge and survival at 1 year were analysed.
Precipitating factors inﬂuenced readmissions and survival. Acute pulmonary disease was associated with fewer readmissions
(HR 0.61, 95% conﬁdence interval (CI) 0.37–0.99, P = 0.049), especially in patients aged 75 years or younger (HR 0.20, 95% CI
0.06–0.63, P = 0.006), whereas atrial ﬁbrillation (HR 2.23, 95% CI 1.29–3.85, P = 0.004) and acute coronary syndrome (HR 2.23,
95% CI 1.02–4.86, P = 0.044) were associated with more readmissions. Patients with acute pulmonary disease at admission
showed higher mortality (HR 1.59, 95% CI 1.04–2.43, P = 0.034), especially in subjects aged 75 years or younger (HR 2.52,
95% CI 1.17–5.41, P = 0.018).
Conclusions Precipitating factors of AHF substantially inﬂuenced outcome after hospitalization. In particular, patients with
AHF precipitated by acute pulmonary disease showed fewer readmissions and higher 1 year mortality, especially in patients
aged 75 years or younger.
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Introduction
Acute heart failure (AHF) is one of the leading causes of
unscheduled hospitalization in patients older than 65 years
and is associated with frequent readmissions and substantial
mortality.1 In recent years, several factors that may contrib-
ute to exacerbation of heart failure have been identiﬁed.
Among these, acute coronary syndrome, arrhythmias and
acute respiratory disease have been identiﬁed as being the
most common precipitating factors.2–5 As shown in the
analysis of the OPTIMIZE-HF registry, which included
patients admitted for AHF in 259 centres in the United
States, precipitating factors of AHF inﬂuenced short-term
outcome.2 In particular, acute coronary syndrome and acute
respiratory disease were associated with higher in-hospital
mortality. In contrast, little evidence is available about the effect
of precipitating factors on readmission and long-term mortality.
We recently showed that the effect on outcome of several
prognostic factors was strongly inﬂuenced by age and was
more pronounced in AHF patients younger than 75 years,
compared with the older ones.6 The aim of the present study
was to assess the effect of precipitating factors of AHF on
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readmission and long-term mortality in the overall popula-
tion of patients admitted for AHF and in the subgroup of
patients aged 75 years or younger.
Methods
Study population and diagnosis groups
Patients with diagnosis of AHF included in the multicentric
prospective cohort ‘Biomarcoeurs’ were analysed in this study.
The ‘Biomarcoeur’ cohort included patients aged 18years or
older admitted to the emergency department of three tertiary
centres (Lariboisière University Hospital in Paris, France,
Fattouma Bourguiba University Hospital in Monastir, Tunisia,
and Cumhuriyet University Hospital in Sivas, Turkey) between
1 January 2010 and 31 December 2013. AHF (including de novo
AHF, acute decompensated heart failure or cardiogenic shock)
was diagnosed by reviewing medical records after hospital dis-
charge and was based on medical history, clinical examination,
natriuretic peptides and additional tests obtained during










Demographics Age (years) 75 (64–84) 78 (66–88) 73 (64–82) 0.001
Male gender 425 (56%) 73 (49%) 352 (58%) 0.053
Clinical signs SBP (mmHg) 140 (120–162) 140 (114–161) 140 (120–162) 0.613
DBP (mmHg) 80 (68–93) 75 (65–90) 80 (70–94) 0.007
Heart rate (per min) 88 (72–105) 90 (76–112) 87 (72–105) 0.067
Respiratory rate (per min) 26 (22–32) 29 (24–34) 26 (22–32) < 0.001
Oxygen saturation (%) 95 (90–97) 93 (88–96) 95 (91–97) < 0.001
Rales 582 (82%) 118 (87%) 464 (81%) 0.081
Wheezing 144 (19%) 65 (44%) 79 (13%) < 0.001
Jugular distension 310 (41%) 54 (36%) 256 (42%) 0.194
Peripheral edema 431 (57%) 77 (52%) 354 (58%) 0.140
Temperature (°C) 36.9 (36.5–37.2) 37 (36.5–37.5) 36.8 (36.5–37.1) < 0.001
Height (cm) 168 (160–173) 167 (159–171) 168 (160–173) 0.058
Weight (kg) 73 (63–85) 75 (62–88) 72 (63–85) 0.880
Comorbidities
Chronic heart failure 358 (47%) 67 (45%) 291 (48%) 0.523
Coronary artery disease 246 (33%) 55 (37%) 191 (32%) 0.207
Prior PCI/CABG 93 (12%) 18 (12%) 75 (12%) 1.000
Peripheral vascular disease 78 (10%) 14 (9.4%) 64 (11%) 0.765
Valve disease 97 (13%) 15 (10%) 82 (14%) 0.278
Atrial ﬁbrillation or ﬂutter 286 (38%) 61 (41%) 225 (37%) 0.398
Hypertension 520 (69%) 103 (69%) 417 (69%) 1.000
Diabetes mellitus 274 (36%) 51 (34%) 223 (37%) 0.570
Dyslipidemia 205 (27%) 34 (23%) 171 (28%) 0.217
Obesity 78 (10%) 16 (11%) 62 (10%) 0.881
Active or recent smoking 137 (18%) 31 (21%) 106 (18%) 0.344
COPD or asthma 132 (18%) 62 (42%) 70 (12%) < 0.001
Chronic kidney disease 106 (14%) 21 (14%) 85 (14%) 1.000
Depression 28 (3.7%) 8 (5.4%) 20 (3.3%) 0.230
Cognitive dysfunction 39 (5.2%) 8 (5.4%) 31 (5.1%) 0.838
Loss of autonomy 21 (2.8%) 11 (7.4%) 10 (1.7%) 0.001
Chronic liver disease 13 (1.7%) 4 (2.7%) 9 (1.5%) 0.299
Active or recent cancer 70 (9.3%) 13 (8.7%) 57 (9.4%) 0.876
Anaemia 37 (4.9%) 8 (5.4%) 29 (4.8%) 0.832
Chronic treatment Betablockers 310 (41%) 61 (41%) 249 (41%) 1.000
ACE-I or ARB 417 (55%) 77 (52%) 340 (56%) 0.358
MRA 104 (14%) 16 (11%) 88 (14%) 0.288
Diuretics 433 (57%) 90 (60%) 343 (57%) 0.407
Antiplatelets 304 (40%) 67 (45%) 237 (39%) 0.193
Biology BNP (pg/mL) 1082 (611–2190) 899 (404–1445) 1191 (643–2329) <0.001
Troponin I (μg/L) 0.05 (0.02–0.129) 0.05 (0.02–0.2) 0.05 (0.02–0.12) 0.403
Troponin T (μg/L) 0.02 (0.01–0.11) 0.04 (0.01–0.2) 0.01 (0.01–0.11) 0.787
Creatinine (μmol/L) 108 (78–146) 106 (79–146) 108 (78–146) 0.838
eGFR (Cockroft) 51.5 (34.9–75) 49.3 (32.4–69.2) 51.6 (35–75) 0.614
CRP (mg/L) 16 (6–42) 35 (10–110) 14 (5–31) < 0.001
Procalcitonin (μg/L) 0.12 (0.08–0.22) 0.16 (0.12–0.36) 0.11 (0.08–0.16) 0.013
ACE-I, angiotensin converting enzyme inhibitor; AHF, acute heart failure; ARB, angiotensin receptor blocker; BNP, brain natriuretic peptide;
CABG, coronary artery bypass grafting; COPD, chronic obstructive pulmonary disease; CRP, c-reactive protein; DBP, diastolic blood pressure;
eGFR, estimated glomerular ﬁltration rate; MRA, mineralocorticoid receptor antagonist; PCI, percutaneous coronary intervention; SBP,
systolic blood pressure.
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hospitalization. Precipitating factors of AHF were assessed and
classiﬁed in four main groups: acute coronary syndrome, atrial
ﬁbrillation with rapid ventricular conduction, acute pulmonary
disease (including chronic obstructive pulmonary disease
exacerbation, asthma and pulmonary infection) and other
causes. The latter group includes undetermined precipitating
factors and all precipitating factors not ﬁtting in the previous
three categories. The diagnosis of AHF in this cohort has been
previously shown to be highly accurate.7 As detailed data
about acute pulmonary disease were not included in the
original database, the adjudication committee veriﬁed and
conﬁrmed the combination of AHF and acute pulmonary
disease.7 Follow-up visits were performed by phone contact
at 1, 3, 6 and 12months after hospital discharge. Hospital
readmission during 90days after hospital discharge and sur-
vival at 1 year after admission were analysed. All patients gave
informed consent. The study was carried out in accordance
with the Declaration of Helsinki and was approved by the insti-
tutional review board of each centre. This study was registered
in clinicaltrials.gov, and the identiﬁer is NCT01374880.
Statistic analysis
Group characteristics were compared with the Fisher’s exact
test or the Mann–Whitney U test, as appropriate. The effects
of the presence compared with absence of every precipitat-
ing factor on 1 year mortality and 90 days readmission rates
were assessed using Cox regression models without and with
adjustment for potential confounding factors (age, sex and im-
paired renal function, deﬁned as eGFR< 60mL/min/1.73m2).
Moreover, the effect of precipitating factors was assessed
in the subgroups of patients older than 75 years and aged
of 75 years or younger. Mortality and readmission were
described with the Kaplan–Meier curve, and differences
between groups were assessed by the log-rank test. The null
hypothesis was rejected with a two-sided P-value< 0.05. All
analyses were performed with the use of IBM SPSS Statistics,
Version 21.0. (IBM Corp, Armonk, NY). Values are expressed as




A total of 755 patients with AHF were included in the analy-
sis. Population characteristics are summarized in Table 1.
The median age was 75 (64–84) years, 56% of patients were
men and clinical signs of congestion were commonly re-
ported: the respiratory rate was 26 per minute (22–32 per
minute), rales were audible during lung auscultation of 582
patients (82%), peripheral edema and jugular distention were
reported in 431 (57%) and 310 (41%) patients, respectively.
Concerning precipitating factors of AHF, acute coronary syn-
drome was present in 47 patients (6%), atrial ﬁbrillation with
Table 2 Precipitating factors and risk of 90 days readmission
Overall, unadjusted Overall, adjusted Patients ≤75 years, adjusted Patients >75 years, adjusted
Precipitating factor HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
Atrial ﬁbrillation 1.29 (0.83–2.00) 0.25 1.46 (0.93–2.29) 0.10 2.23 (1.29–3.85) 0.004 0.74 (0.33–1.67) 0.47
Acute coronary syndrome 1.38 (0.70–2.72) 0.35 1.36 (0.66–2.79) 0.40 2.23 (1.02–4.86) 0.044 0.34 (0.05–2.51) 0.29
Acute pulmonary disease 0.61 (0.37–0.99) 0.049 0.65 (0.39–1.08) 0.10 0.20 (0.06–0.63) 0.006 1.36 (0.72–2.56) 0.35
Other 1.12 (0.78–1.62) 0.54 0.99 (0.68–1.44) 0.95 0.98 (0.60–1.59) 0.92 1.02 (0.56–1.85) 0.95
AHF, acute heart failure; CI, conﬁdence interval.
Risk of 90 days readmission in presence of predeﬁned classes of precipitating factors of AHF compared with absence of the same factor.
Adjustment was performed for age, sex and impaired renal function.
Figure 1 Levels of BNP and CRP (C-reactive protein) at admission in the
group of patients with acute heart failure precipitated by acute pulmo-
nary disease (n = 149) compared with acute heart failure precipitated
by non-pulmonary causes (n = 606). Median and 95% conﬁdence interval
are displayed.
No acute pulmonary diseaseAcute pulmonary disease
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rapid ventricular response in 127 patients (17%) and acute
pulmonary disease in 149 patients (20%). In 459 patients
(61%), AHF was precipitated by other causes. Of note, in 27
patients (4%), a combination of acute coronary syndrome
and atrial ﬁbrillation was identiﬁed as precipitating factor.
Characteristics of patients with acute heart failure
precipitated by acute pulmonary disease
As summarized in Table 1, patients with AHF precipitated by
acute pulmonary disease were older (78 years vs. 73 years),
reported more often previous history of chronic obstructive
pulmonary disease or asthma (42% vs. 12%), suffered from
greater respiratory impairment (higher respiratory rate and
lower peripheral oxygen saturation) and showed more often
wheezing on lung auscultation (44% vs. 13%) than patients
with AHF precipitated by non-pulmonary causes. As illus-
trated in Figure 1, patients with AHF precipitated by acute
pulmonary disease had higher levels of C-reactive protein
[35mg/L (10–110mg/L) vs. 14mg/L (5–31mg/L), P< 0.001]
but lower levels of BNP [899 pg/mL (404–1445 pg/mL) vs.
1191 pg/mL (643–2329 pg/mL), P< 0.001] compared with
the group of AHF precipitated by non-pulmonary causes.
Precipitating factors of acute heart failure and
readmission rates
Precipitating factors signiﬁcantly inﬂuenced the 90days read-
mission rates, as shown in Table 2. In the overall population,
acute pulmonary disease was associated with lower readmis-
sion rates (hazard ratio (HR) 0.61, 95% conﬁdence interval
(CI) 0.37–0.99, P= 0.049), whereas atrial ﬁbrillation with rapid
ventricular response, acute coronary syndrome and other
precipitating factors showed a non-signiﬁcant trend towards
higher readmission rates. After adjustment for potential
confounding factors, none of the precipitating factors signiﬁ-
cantly inﬂuenced the readmission rates. As shown in Figure 2
(left panel), the subgroup of patients with AHF precipitated by
acute pulmonary disease (n=149) showed fewer readmissions
(log-rank P=0.047) compared with the subgroup of patients
with AHF precipitated by non-pulmonary causes (n=606).
In the subgroup of patients aged 75 years or younger, dif-
ferences were even more pronounced: as shown in Table 2,
after adjustment for potential confounding factors, acute
pulmonary disease was associated with markedly lower read-
mission rates (HR 0.20, 95% CI 0.06–0.63, P = 0.006), whereas
atrial ﬁbrillation (HR 2.23, 95% CI 1.29–3.85, P = 0.004) and
acute coronary syndrome (HR 2.23, 95% CI 1.02–4.86,
Figure 2 Readmissions of patients with acute heart failure precipitated by acute pulmonary disease compared with acute heart failure precipitated by
non-pulmonary causes during 90 days after discharge in the overall population and in the subgroup of patients ≤75 years.
Table 3 Precipitating factors and risk of 1 year mortality
Overall unadjusted Overall adjusted Patients ≤75 years, adjusted Patients >75 years, adjusted
Factor HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
Atrial ﬁbrillation 0.66 (0.36–1.21) 0.18 0.63 (0.34–1.15) 0.13 0.50 (0.12–2.16) 0.35 0.67 (0.34–1.31) 0.24
Acute coronary syndrome 0.96 (0.42–2.19) 0.92 1.00 (0.44–2.29) 1.00 --a 0.98 1.49 (0.64–3.46) 0.35
Acute pulmonary disease 1.59 (1.04–2.43) 0.034 1.46 (0.94–2.25) 0.09 2.52 (1.17–5.41) 0.018 1.03 (0.61–1.75) 0.91
Other 0.90 (0.60–1.33) 0.59 0.95 (0.64–1.43) 0.82 0.72 (0.35–1.50) 0.38 1.06 (0.66–1.71) 0.81
AHF, acute heart failure; CI, conﬁdence interval.
Risk of 1 year mortality in presence of predeﬁned classes of precipitating factors of AHF compared with absence of the same factor.
Adjustment was performed for age, sex and impaired renal function.
aNo risk calculation possible because of lack of events in this subgroup.
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P=0.044) were associated with higher readmission rates. As
illustrated in Figure 2 (right panel), younger patients with
AHF precipitated by acute pulmonary disease showed fewer
readmissions compared with the subgroup of patients with
AHF precipitated by non-pulmonary causes (log-rank P=0.003).
Precipitating factors of acute heart failure and
survival at 1year
As shown in Table 3, acute pulmonary disease at admission
was associated with higher mortality at 1 year in the overall
population (HR 1.59, 95% CI 1.04–2.43, P = 0.034), whereas
all three other groups of precipitating factors were not. After
adjustment for potential confounding factors, acute pulmo-
nary disease showed only a non-signiﬁcant trend towards
higher risk of death in the overall population (HR 1.46, 95%
CI 0.94–2.25, P = 0.09). As illustrated in Figure 3 (left panel),
patients with AHF precipitated by acute pulmonary disease
showed increased mortality during 1 year follow-up com-
pared with the subgroup of patients with AHF precipitated
by non-pulmonary causes (log-rank P = 0.032).
More interestingly, in the subgroup of patients aged
75 years or younger, acute pulmonary disease was associated
with signiﬁcantly higher risk of death (HR 2.52, 95% CI
1.17–5.41, P = 0.018). As illustrated in Figure 3 (right panel),
younger patients with AHF precipitated by acute pulmonary
disease showed higher mortality compared with the sub-
group of patients with AHF precipitated by non-pulmonary
causes (log-rank P = 0.026).
Discussion
The inﬂuence of precipitating factors on outcome, described
in the present paper, extends the concept proposed by
Fonarow and co-workers after analysis of the OPTIMIZE-HF
registry.2 Fonarow and co-workers showed an association
between acute coronary syndrome (ACS), pulmonary infec-
tion and higher in-hospital mortality, but no data exist on
the inﬂuence of precipitating factors on post-discharge
readmissions and long-term mortality. The present study
demonstrated that precipitating factors of AHF may substan-
tially inﬂuence outcome far beyond the duration of hospital-
ization, especially in patients aged 75 years or younger:
readmission rates were low when acute pulmonary disease
precipitated AHF and high when non-acute pulmonary dis-
ease, including atrial ﬁbrillation or acute coronary syndrome,
precipitated AHF. Regarding long-term survival, acute pulmo-
nary disease was also associated with higher mortality.
The inﬂuence of precipitating factors of AHF on post-
discharge readmission rate, in patients aged 75 years or
younger, is a novel observation. The existence of congestion
is a frequent cause of hospital readmission in patients with
chronic heart failure.8 In the present study, the subgroup
with acute pulmonary disease, as precipitating cause of
AHF, showed lower levels of BNP suggesting a lower level
of congestion compared with patients with non-pulmonary
precipitating factors. Furthermore, patients with acute pul-
monary diseases, including infections, once treated, are usu-
ally discharged home with rare readmissions. The inﬂuence
of acute pulmonary disease on post-discharge readmission
rate was mostly seen in patients aged 75 years or younger,
while no inﬂuence of precipitating factors on readmissions
in older AHF patients. We recently showed that effect of
several prognostic factors was inﬂuenced by age and was
more pronounced in AHF patients younger than 75 years,
compared with the older ones.6 Results of the present study
conﬁrm the stronger relationship between prognostic factors
and outcome in younger patients, although the reasons
remain unknown: a more complex interaction between pre-
cipitating factors, multimorbidity and frailty of older patients
with AHF could be a reasonable explanation.
Figure 3 Mortality of patients with acute heart failure precipitated by acute pulmonary disease compared with acute heart failure precipitated by non-
pulmonary causes during 1 year after admission in the overall population and in the subgroup of patients ≤75 years.
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Surprisingly, the observed inﬂuence of acute pulmonary
disease on long-term mortality was divergent from that on re-
admission: patients with AHF exacerbated by acute pulmonary
disease showed higher mortality. Two recently published stud-
ies showed that pneumonia is associated with increased risk
for cardiovascular events after hospital discharge.9,10 A combi-
nation of endothelial dysfunction, plaque instability, activated
coagulation,11 volume overload, inﬂammatory and ischemic
myocardial injury12 and arrhythmias13 have been postulated
to explain increased morbidity and mortality. It is still unclear
whether the adverse prognosis of the subgroup of admitted
for AHF precipitated by acute pulmonary disease is caused by
the unfavourable association of AHF and pulmonary disease
itself or is rather a marker of a more complex co-morbidity
proﬁle in patients with such an association.
Our study suggests that the peculiar pathophysiological
background of AHF precipitated by acute pulmonary disease
exposes those patients to increased risk of death despite
fewer readmissions. As a consequence, those patients should
beneﬁt not only from aggressive initial treatment but also
from a more intensive and interdisciplinary follow-up after
hospital discharge.
Limitations
The study was conducted on a medium-sized cohort of pa-
tients with AHF from three tertiary centres. Therefore, the
conclusions of this study should be conﬁrmed in larger
cohorts. However, this cohort was large enough to demonstrate
signiﬁcant differences between the different precipitating
factors. Moreover, the group of ‘other precipitating factors’
was quite large, as our database was not conceived for further
differentiation among other causes of AHF. This group might
include patients with AHF precipitated by other causes as
hypertension, malcompliance and worsening renal function.3–5
Despite outcome data were derived from telephonic follow-
up and relevant censoring (287 patients, 38%) occurred, the
median follow-up in the cohort was 320days. In addition, the
cause of readmission was not assessed during follow-up, and
therefore, the risk of a potential bias derived from new-onset
precipitating factors, although small, cannot be excluded.
Conclusions
Precipitating factors of AHF substantially inﬂuence outcome
after hospitalization. In particular, patients with AHF precipi-
tated by acute pulmonary disease showed fewer readmissions
and higher 1 year mortality, especially in patients aged 75 years
or younger.
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